Medical Frontiers

25.8. 16:30

NHK WORLD-JAPAN

30 minut

While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30% of patients. We interview Japanese researchers who are trying to overcome this challenge.

Więcej informacji

Nagraj

O audycji

angielski

While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30% of patients. We interview Japanese researchers who are trying to overcome this challenge.